InvestorsObserver
×
News Home

Should Biotechnology Stock Day One Biopharmaceuticals Inc (DAWN) Be in Your Portfolio Friday?

Friday, August 12, 2022 01:59 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Day One Biopharmaceuticals Inc (DAWN) Be in Your Portfolio Friday?

Day One Biopharmaceuticals Inc (DAWN) is around the top of the Biotechnology industry according to InvestorsObserver. DAWN received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Day One Biopharmaceuticals Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 28 out of the 148 industries.

Overall Score - 79
DAWN has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on DAWN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Day One Biopharmaceuticals Inc Stock Today?

Day One Biopharmaceuticals Inc (DAWN) stock is trading at $26.45 as of 1:57 PM on Friday, Aug 12, a gain of $1.95, or 7.96% from the previous closing price of $24.50. The stock has traded between $24.65 and $28.35 so far today. Volume today is 571,211 compared to average volume of 490,520. Click Here to get the full Stock Report for Day One Biopharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App